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Swerdlow et al. (2004) addressed in their recent paper the
possible relation between prepulse-elicited reactivity and
prepulse inhibition, which was raised by Dahmen and Corr
(2004) in healthy human subjects and by us in mice (Yee
et al. 2004a,b). In their report, Swerdlow and colleagues
showed that prepulse inhibition (PPI) can be reliably
demonstrated with prepulses that do not generate observ-
able reactivity by employing (unusually) weak prepulses
in the range of 1–5 dB above background noise. Whilst we
concur that the presence of measurable prepulse-elicited
reactivity is not a prerequisite for the generation of PPI, we
feel that it is premature to discourage speculation concern-
ing the potential theoretical and practical relevance of
prepulse-elicited response measures to PPI. Because of this
and our shared interest in the psychopharmacology of
prepulse processing with respect to the expression of PPI,
we feel obliged to add a few clarifications concerning the
relevance of our data (Yee et al. 2004a) cited by Swerdlow
and colleagues in their report.
First, although the positive correlation we obtained be-
tween prepulse-elicited reactivity (4–16 dB above back-
ground) and PPI magnitude in mice was opposite to the
relationship reported by Dahmen and Corr (2004) between
prepulse response probability and PPI in humans, our
finding on the effects of apomorphine (2 mg/kg, s.c.) is in
agreement with the relationship described by Dahmen and
Corr (2004): apomorphine reduces PPI and concomitantly
enhances prepulse-elicited reactivity (see Fig. 1, Yee et al.
2004a, pp. 243).
Second, contrary to their claim, it is our view that the effect
of apomorphine (0.5mg/kg, s.c.) reported by Swerdlow et al.
(2004) is not consistent with what we demonstrated pre-
viously in mice (Yee et al. 2004a). Swerdlow and colleagues
elected to emphasize the non-significant elevation of reac-
tivity obtained on trials without any explicit stimulus (i.e.,
“no stimulus” trials) in our Experiments 1 and 3 (the per-
centage elevation for Experiment 3 should be 37.2%, but not
46.3% as mistakenly calculated by Swerdlow et al. on the
basis of Table 1 in Yee et al. 2004a). What has been over-
looked is that against this non-significant change in reactiv-
ity on no-stimulus trials, apomorphine led to a significant
increase in the reactivity in prepulse-alone trials including
the weakest prepulse at +4 dB over background (see Figs. 1c
and 3c, Yee et al. 2004a). Hence, their conclusion that
apomorphine “does not selectively affect these [prepulse-
related] variables on trials with prepulses” (Swerdlow et al.
2004, p. 1196) does not apply to our data.
This is also the case when we re-examined our data
(Experiment 1, Yee et al. 2004a) using the measure of
“response probability” following the definition by Dahmen
and Corr (2004), as did Swerdlow et al. (2004). Expressed
as response probability deviation from no-stimulus trials,
we obtained a clear effect [F(1,77)=8.00, p=0.006] of apo-
morphine across all prepulse intensities examined includ-
ing the weakest +4 dB prepulse (see Fig. 1 here). Again,
this contrasts with Swerdlow et al.’s observation that “in
apomorphine-treated rats, prepulses alone did not increase
either response probability or mean motor activity com-
pared with no stimulus” (Swerdlow et al. 2004, p. 1197).
Third, with the specific aim to examine weak prepulses
alone, Swerdlow et al. (2004) had excluded prepulses of
higher magnitude. This is unfortunate because PPI studies
in both human and animals typically employ prepulse
extending up to +16 dB over background. In the literature,
conclusions have been drawn based on effects on PPI that
were only clearly seen at prepulse intensities that are
clearly not weak by Swerdlow et al.’s standard. Thus, the
possibility that prepulse-elicited reactivity may be a con-
founding (though may not be causally related, see Yee et
al. 2004b) variable in human and rodent measures of PPI
needs to be considered seriously.
Lastly, given that the apparatus routinely employed is
not designed to measure the low-level response expected
from prepulse-alone presentation, it is not surprising that at
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sufficiently low intensities prepulse alone may not yield
clearly observable reaction beyond the baseline (no stim-
ulus) level. The conceptual distinction between weak and
non-weak prepulses therefore warrants critical examina-
tion. Technical advances in the future will allow a closer
and more accurate characterization of prepulse-elicited re-
action in the context of PPI, and we encourage additional
experiments in this direction.
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Fig. 1 The effect of systemic apomorphine (2 mg/kg, s.c.) on
prepulse-elicited response as reported in Experiment 1 of Yee et al.
(2004a) was expressed using the measure of “response probability”,
as described by Dahmen and Corr (2004). Here, prepulse-elicited
reactivity on each of the four prepulse intensities is depicted as
deviation from that obtained on no-stimulus trials. A 2×4 (drug
treatment × prepulse levels) ANOVA yielded a clear main effect of
drug treatment, which was consistent with the conclusion based on a
more direct measure of response magnitude as described in the
original report. Error bars refer to ±SEM
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